Similarly, Cur analog A501 also promotes the apoptosis of NSCLC cells by inhibiting cyclinB1, cdc-2, and Bcl-2 and activating p53 and caspase-3 [149]. Here, CASP3 is linked to non-small cell lung carcinoma.